Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001714899-25-000105
Filing Date
2025-05-06
Accepted
2025-05-06 16:04:50
Documents
75
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q dnli-20250331.htm   iXBRL 10-Q 1284980
2 EX-10.1 genzymenoticeofpartialterm.htm EX-10.1 22904
3 EX-10.2 takedanoticeofpartialtermi.htm EX-10.2 9047
4 EX-10.3 amendedoutsidedirectorcomp.htm EX-10.3 52144
5 EX-31.1 exhibit311q12025.htm EX-31.1 9891
6 EX-31.2 exhibit312q12025.htm EX-31.2 9911
7 EX-32.1 exhibit321q12025.htm EX-32.1 5550
8 EX-32.2 exhibit322q12025.htm EX-32.2 5679
14 image1.jpg GRAPHIC 19105
15 image_0.jpg GRAPHIC 8812
16 image_1.jpg GRAPHIC 6676
17 picture1.jpg GRAPHIC 17313
  Complete submission text file 0001714899-25-000105.txt   6224253

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dnli-20250331.xsd EX-101.SCH 43656
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dnli-20250331_cal.xml EX-101.CAL 63610
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dnli-20250331_def.xml EX-101.DEF 179549
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dnli-20250331_lab.xml EX-101.LAB 581057
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dnli-20250331_pre.xml EX-101.PRE 391646
78 EXTRACTED XBRL INSTANCE DOCUMENT dnli-20250331_htm.xml XML 697599
Mailing Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 (650) 866-8547
Denali Therapeutics Inc. (Filer) CIK: 0001714899 (see all company filings)

EIN.: 463872213 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38311 | Film No.: 25917165
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)